Investment Opportunity

A hard asset and an IP asset, funded in one round.

Sensus Health is raising to secure real estate and complete build-out of an 80-bed upscale assisted living residence in Miami, staffed for genuinely attentive human care, and to fund development of the Care Haven platform. The residence generates operating yield; the platform is positioned to compound as licensable intellectual property.

Golden hour exterior of an upscale Miami assisted living residence nearing completion, with a construction crane in the distance
$24.0M
Total raise target
80
Licensed beds at stabilization
3
Development phases to open
2
Distinct asset classes

The thesis

Why this business, and why now.

01

Demand is structural, not cyclical

South Florida's aging population continues to outpace licensed capacity, and the upscale segment remains fragmented among small operators without real technology.

02

The platform is the differentiator

Care Haven is not a vendor subscription. It is owned intellectual property built to Sensus specifications, positioned for patent protection and later licensing.

03

Clinically founded operations

The care model is authored by a practicing clinical social worker, which lowers the operational and compliance risk that sinks first-time operators.

04

Two exits, not one

Investors are exposed to a stabilized real-estate asset and, separately, to the upside of a licensable platform that scales without new buildings.

Use of funds

Where the capital goes.

Real estate acquisition$11.5M
Build-out & interiors$7.2M
Care Haven platform development$3.4M
Working capital & contingency$1.9M
Total raise target$24.0M

The IP position

Care Haven as a balance-sheet asset.

Sensus Health intends to pursue patent protection for Care Haven and hold it as an owned asset rather than a licensed dependency. Once the flagship residence proves the model, the same platform can be licensed to other operators, revenue that does not require another building, another license, or another payroll.

OwnershipSensus Health, Inc. retains the IP
DevelopmentBuilt to Sensus clinical specifications
ProtectionPatent strategy in progress
MonetizationOperator licensing after flagship validation
Request the investor memo

Disclosures

Figures on this page are illustrative planning targets, not guaranteed outcomes or audited projections.

Care Haven capabilities are described as a product vision under active development.

Nothing on this site constitutes an offer to sell or a solicitation to buy securities.

Detailed financial models, entity structure, and terms are shared only with qualified prospective investors under NDA.